title: Close encounters with errors of the second kind: evaluating risks and benefits of long-term dual antiplatelet therapy.
authors: Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
authors: Robert W
authors: RW
authors: Yeh
authors: St. Luke's Mid America Heart Institute, Kansas City, MO, USA.
authors: David J
authors: DJ
authors: Cohen
authors: Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA lmauri1@partners.org.
authors: Laura
authors: L
authors: Mauri
mesh_terms: D054058:Acute Coronary Syndrome / Q000628:therapy*; D001241:Aspirin / Q000008:administration & dosage*; D003324:Coronary Artery Disease / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin